. MTT cell viability assays were performed in the class II (MDA-MB-231) and class III (H1666) BRAF-mutant cell lines, to compare the IC50s of two distinct SHP2 inhibitors: SHP099 and RMC-4550. IC50: half maximal inhibitory concentration.
. MTT cell viability assays were performed in the class II (MDA-MB-231) and class III (H1666) BRAF-mutant cell lines, to compare the effect of single MEK (trametinib) and single SHP2 (RMC-4550) treatment, or combined treatment on cell viability (A) and to compare the effect of single BRAF (dabrafenib) and single SHP2 (RMC-4550) treatment, or combined treatment on cell viability (B). The isobolograms depict combination index (CoI) values at each drug concentration, calculated based on the Chou and Talalay method. Average CoIs are depicted in the graph, and CoI values <1, = 1, and >1 indicate synergism, additive effect and antagonism, respectively. Experiments were performed in biological triplicates with similar results, and representative graphs are shown. 
